About Surien Pharmaceuticals
Surien Pharmaceuticals is a company based in Chennai (India) founded in 2001. It operates as a B2B. Surien Pharmaceuticals offers products and services including TRICOBAL OD, INGLIB-M, ACE 1000, PANSafe-DSR, and ATOSKY A 75. Surien Pharmaceuticals operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Chennai, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Surien Pharmaceuticals Private Limited
- Date of Incorporation 19 Apr, 2004
- Jurisdiction Chennai, Tamil Nadu, India
-
Annual Revenue
$2.36 M (USD)-38.04as on Mar 31, 2024
-
Net Profit
$9.85 K (USD)83.66as on Mar 31, 2024
-
EBITDA
$223.08 K (USD)41.33as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Surien Pharmaceuticals
Surien Pharmaceuticals offers a comprehensive portfolio of products and services, including TRICOBAL OD, INGLIB-M, ACE 1000, PANSafe-DSR, and ATOSKY A 75.
Restores nutritional deficiency states through oral administration.
Addresses specific medical conditions with targeted formulations.
Manages health issues via effective pharmaceutical delivery.
Provides rapid relief from acid-related disorders.
Supports heart health and reduces ischemic events.
Funding Insights of Surien Pharmaceuticals
Detailed funding history for Surien Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Surien Pharmaceuticals
Investment portfolio details for Surien Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Surien Pharmaceuticals
Detailed financials for Surien Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Surien Pharmaceuticals Comparisons
Peer comparison for Surien Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Surien Pharmaceuticals
Surien Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Surien Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Surien Pharmaceuticals
Complete news archive for Surien Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surien Pharmaceuticals
Surien Pharmaceuticals was founded in 2001.
Surien Pharmaceuticals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Annual revenue of Surien Pharmaceuticals is $2.36M as on Mar 31, 2024.
Surien Pharmaceuticals, based in Chennai, India, is a WHO-GMP and ISO-certified company that produces tablets, capsules, syrups, and other pharmaceutical forms. They utilize advanced equipment and an RD team for quality manufacturing and testing. The company exports to countries like Sri Lanka and supplies products to leading Indian firms on a business-to-business basis, focusing on nutritional and therapeutic solutions.
Surien Pharmaceuticals's top competitors include Merck, Roivant Sciences and AbbVie.
Surien Pharmaceuticals offers TRICOBAL OD, INGLIB-M, ACE 1000, PANSafe-DSR, and ATOSKY A 75.